SCHEMBL310968

SCHEMBL310968

CC(N)c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.48
CYP3A4 P08684 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
NFKB1 P19838 1/20 0.45
PNMT P11086 1/20 0.45
IDO1 P14902 2/20 0.44
TDO2 P48775 2/20 0.44
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
ACHE P22303 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
HIF1A Q16665 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23139487 1.00 PDE2A (0.48) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
SCHEMBL1003465 1.00 PDE2A (0.48) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
SCHEMBL29621462 1.00 PDE2A (0.48) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
SCHEMBL29394861 1.00 PDE2A (0.48) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
SCHEMBL335364 1.00 PDE2A (0.48) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
Hydrochloric Acid SCHEMBL4226725 0.98 IDO1 (0.47) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
Hydrochloric Acid SCHEMBL29669123 0.98 IDO1 (0.47) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
Iodide SCHEMBL28964924 0.98 PDE2A (0.47) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
Bromide SCHEMBL28598190 0.98 PDE2A (0.47) PDE2ACYP3A4CYP1A2CYP2D6NFKB1
Hydrochloric Acid SCHEMBL20237990 0.98 IDO1 (0.47) PDE2ACYP3A4CYP1A2CYP2D6NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120018406-A Fine circuit pattern diffusion inhibitor and preparation method and application method thereof 深圳市板明科技股份有限公司 2025-05-16 CN claimed
CN-119923165-A Solar cell, preparation method thereof, photovoltaic module, system and power utilization device 宁德时代新能源科技股份有限公司 2025-05-02 CN claimed
CN-118853145-A Laser gain medium stable in air for long time and preparation method thereof 电子科技大学长三角研究院(衢州) 2024-10-29 CN claimed
CN-118614160-A Perovskite solar cell, preparation method thereof and power utilization device 宁德时代新能源科技股份有限公司 2024-09-06 CN claimed
CN-117859209-A Perovskite solar cell and preparation method thereof 宁德时代新能源科技股份有限公司 2024-04-09 CN claimed
CN-117442609-A Application of tetrahydrocarbazole derivative in preventing and treating cow mastitis pathogenic bacteria 兰州大学 2024-01-26 CN claimed
CN-117281120-A Application of tetrahydrocarbazole derivative in preventing and controlling agricultural bacterial diseases 兰州大学 2023-12-26 CN claimed
CN-117202748-A Perovskite film and preparation method and application thereof 上海科技大学 2023-12-08 CN claimed
WO-2023216132-A1 PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR 宁德时代新能源科技股份有限公司 2023-11-16 WO claimed
CN-117015252-A Solar cell with combined action of cesium salt and organic aromatic amine salt and preparation method thereof 电子科技大学 2023-11-07 CN claimed
CN-111974166-A Regenerable solvent mixtures for acid gas separation 三角形研究学会 2020-11-24 CN claimed
US-10166503-B2 Water control in non-aqueous acid gas recovery systems RESEARCH TRIANGLE INSTITUTE (US) 2019-01-01 US claimed
US-20170050140-A1 WATER CONTROL IN NON-AQUEOUS ACID GAS RECOVERY SYSTEMS U.S. DEPARTMENT OF ENERGY 2017-02-23 US claimed
EP-3104957-A1 WATER CONTROL IN NON-AQUEOUS ACID GAS RECOVERY SYSTEMS Research Triangle Institute (US) 2016-12-21 EP claimed
WO-2014001075-A1 PROCESS FOR RACEMIZING OPTICALLY ACTIVE ARYLALKYLAMINES BASF SE (DE) 2014-01-03 WO claimed
US-20130345475-A1 PROCESS FOR THE RACEMIZATION OF OPTICALLY ACTIVE ARYLALKYLAMINES BASF SE (DE) 2013-12-26 US claimed
EP-2006271-A9 SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2009-07-29 EP claimed
US-20090054401-A1 Substituted bicyclic derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2009-02-26 US claimed
EP-2006271-A2 SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2008-12-24 EP claimed
US-4209638-A RESOLUTION OF ENANTIOMORPHS THE BOOTS COMPANY LIMITED (GB) 1980-06-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054401-A1 Substituted bicyclic derivatives and use thereof LTB4R2, LTC4S, LTB4R PDE2A 1793/4885CYP3A4 1212/4885CYP1A2 612/4885
US-20130345475-A1 PROCESS FOR THE RACEMIZATION OF OPTICALLY ACTIVE ARYLALKYLAMINES HRH1, HNMT, HRH3 PDE2A 3501/4885CYP3A4 24/4885CYP1A2 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.